A Perspective on Biofuels Use and CCS for GHG Mitigation in the Marine Sector

The greenhouse gasoline (GHG) emissions of the marine sector had been round 2.6% of world GHG emissions in 2015 and are anticipated to extend 50%-250% to 2050 below a “enterprise as common” state of affairs, making the decarbonization of this fossil fuel-intensive sector an pressing precedence. Biofuels, which are available varied types, are one of the promising choices to exchange current marine fuels for carrying out this within the quick to medium time period. Some distinctive challenges, nevertheless, impede biofuels penetration within the transport sector, together with the low value of the prevailing fuels, the in depth present-day refueling infrastructure, and the exclusion of the sector from the Paris local weather settlement.

To deal with this, it’s essential to first determine these biofuels finest fitted to deployment as marine gasoline. On this work, the lengthy listing of attainable biogasoline candidates has been narrowed right down to 4 high-potential options-bio-methanol, bio-dimethyl ether, bio-liquefied pure gasoline, and bio-oil. These choices are additional evaluated primarily based on six criteria-cost, potential availability, current expertise standing, GHG mitigation potential, infrastructure compatibility, and carbon seize and storage (CCS) compatibility-via each an in depth literature overview and stakeholder discussions.

These 4 candidates change into comparatively evenly matched total, however every possesses sure strengths and shortcomings that might favor that gasoline below particular circumstances, similar to if compatibility with current transport infrastructure or with CCS deployment develop into pivotal necessities. Moreover, we pay explicit consideration to the potential of integrating deployment of those biofuels with CCS to additional scale back marine sector emissions. It’s proven that this side is presently not on the radar of the trade stakeholders however is prone to develop in significance as CCS acceptability will increase within the broader inexperienced vitality sector.

 

Bisphosphonate-associated osteonecrosis of the jaw: systematic overview

Goal: The aim of this systematic overview was to find out the attainable danger components associated to pathophysiology of Bisphosphonate-Associated Osteonecrosis of the Jaw (BRONJ) and determine sufficient therapy methods obtainable and success charges.
Proof acquisition: We carried out a seek for publications in regards to the therapy of BRONJ, printed between 2003 and 2018 within the PubMed/Medline knowledge base utilizing the important thing phrases: ‘Bisphosphonate-Related Osteonecrosis of the Jaw’ OR ‘Bisphosphonate Osteonecrosis’ OR ‘BRONJ’, primarily based on the listing of MeSH and DeCS.
Proof synthesis: In line with preestablished standards for knowledge assortment regarding the therapy of BRONJ, we discovered 19 articles overlaying a complete of 400 sufferers. Remedies that confirmed good outcomes had been Ozone, PRF, PRP/Debridement/Laser bio-stimulation, Laser surgical procedure and Laser surgical procedure/Laser bio-stimulation. HBO didn’t obtain good outcomes and was utilized in solely 10 sufferers. BRONJ is a uncommon situation in sufferers with osteoporosis/different pathologies utilizing BP orally. These sufferers had lengthy publicity time and cumulative doses of BPs till onset of the lesion. The oncological sufferers had been uncovered to stronger intravenously administered BPs similar to pamidronate and zoledronate. These sufferers had a shorter publicity time till onset of the lesion.
Conclusions: The therapy of BRONJ remains to be below debate and there are promising remedies that want randomized trials with bigger numbers of sufferers to substantiate their outcomes. Sufferers receiving BPs or those that will begin therapy needs to be inspired to carry out preventive dental therapy and preserve good oral hygiene.
A Perspective on Biofuels Use and CCS for GHG Mitigation in the Marine Sector
A Perspective on Biofuels Use and CCS for GHG Mitigation in the Marine Sector

A comparability of the efficacy and security of complementary and different therapies for gastroesophageal reflux illness: A protocol for community meta-analysis

Background: Gastroesophageal reflux illness (GERD) is among the most typical gastrointestinal ailments on this planet and is exhibiting growing prevalence in some nations. The illness has a persistent course that results in a big decline within the high quality of lifetime of sufferers and is related to a excessive financial burden worldwide. And complementary and different medication is used to deal with the illness. Over the previous few a long time, quite a lot of randomized managed trials and systematic evaluations have been carried out to guage the effectiveness and security of various kinds of complementary and different medication strategies, so there may be an pressing must summarize and additional consider these research.
Strategies: We are going to search the next sources with out restrictions for date, language, or publication standing: PubMed, Cochrane Central Register of Managed Trials (CENTRAL) Cochrane Library, and EMBASE, China Nationwide Information Infrastructure, Chinese language Bio-medicine Database, VIP Chinese language Periodical Database, Wan Fang Database. We are going to apply a mixture of Medical Topic Heading and free-text phrases incorporating database-specific managed vocabularies and textual content phrases to implement search methods. We can even search the continuing trials registered within the World Well being Group’s Worldwide Medical Trials Registry Platform. Moreover, the earlier related critiques carried out on complementary and different therapies for GERD and reference lists of included research can even be searched.
Outcomes: This research will present a dependable foundation for the therapy of GERD with complementary and different therapies.

Myosin Light Chain 1 antibody

10-M22A 1 mg
EUR 330
Description: Mouse monoclonal Myosin Light Chain 1 antibody

Myosin Light Chain 2 antibody

20R-1971 50 ug
EUR 337.2
Description: Rabbit polyclonal Myosin Light Chain 2 antibody

Myosin Light Chain 2 antibody

20R-2327 50 ug
EUR 337.2
Description: Rabbit polyclonal Myosin Light Chain 2 antibody

Myosin Light Chain 2 antibody

70R-37593 100 ug
EUR 327.6
Description: Rabbit Polyclonal Myosin Light Chain 2 antibody

Myosin Light Chain 2 Antibody

49023-100ul 100ul
EUR 399.6

Myosin Light Chain 2 Antibody

49023-50ul 50ul
EUR 286.8

anti- Myosin Light Chain 2 antibody

FNab05519 100µg
EUR 606.3
Description: Antibody raised against Myosin Light Chain 2

anti- Myosin Light Chain 2 antibody

FNab05520 100µg
EUR 658.5
Description: Antibody raised against Myosin Light Chain 2

Myosin light chain kinase Antibody

48846-100ul 100ul
EUR 399.6

Myosin light chain kinase Antibody

48846-50ul 50ul
EUR 286.8

Myosin Light Chain 3 (MYL3) Antibody

20-abx241038
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Myosin Light Chain 3 (MYL3) Antibody

20-abx241039
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Myosin Light Chain 3 (MYL3) Antibody

abx235487-100ug 100 ug
EUR 577.2

Myosin Light Chain 3 (MYL3) Antibody

20-abx104657
  • EUR 510.00
  • EUR 159.60
  • EUR 1446.00
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myosin Light Chain 3 (MYL3) Antibody

20-abx173688
  • EUR 1028.40
  • EUR 526.80
  • 1 mg
  • 200 ug

Myosin Light Chain 4 (MYL4) Antibody

20-abx217011
  • EUR 510.00
  • EUR 410.40
  • 100 ug
  • 50 ug

Myosin Light Chain 3 (MYL3) Antibody

20-abx121647
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Myosin Light Chain 3 (MYL3) Antibody

20-abx322694
  • EUR 526.80
  • EUR 393.60
  • 100 ul
  • 50 ul

Myosin Light Chain 3 (MYL3) Antibody

20-abx322695
  • EUR 526.80
  • EUR 393.60
  • 100 ul
  • 50 ul

Myosin Light Chain 3 (MYL3) Antibody

abx331063-100ul 100 ul
EUR 510

Myosin Light Chain 3 (MYL3) Antibody

20-abx113951
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Myosin Light Chain 4 (MYL4) Antibody

abx031027-400ul 400 ul
EUR 627.6

Myosin Light Chain 4 (MYL4) Antibody

abx031027-80l 80 µl
EUR 343.2

Myosin Light Chain 3 (MYL3) Antibody

abx016041-100ul 100 ul
EUR 493.2

Myosin Light Chain 3 (MYL3) Antibody

abx018662-100ul 100 ul
EUR 410.4

Myosin Light Chain 3 (MYL3) Antibody

abx028088-400ul 400 ul
EUR 627.6

Myosin Light Chain 3 (MYL3) Antibody

abx028088-80l 80 µl
EUR 343.2

Myosin Light Chain 3 (MYL3) Antibody

20-abx129836
  • EUR 526.80
  • EUR 159.60
  • EUR 1479.60
  • EUR 710.40
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myosin Light Chain 3 (MYL3) Antibody

20-abx323754
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Myosin Light Chain 3 (MYL3) Antibody

20-abx002907
  • EUR 493.20
  • EUR 710.40
  • 100 ul
  • 200 ul

Myosin Light Chain 3 (MYL3) Antibody

20-abx005108
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Myosin Light Chain 3 (MYL3) Antibody

abx011222-100ul 100 ul
EUR 493.2

Myosin Light Chain 3 (MYL3) Antibody

20-abx015098
  • EUR 376.80
  • EUR 117.60
  • EUR 477.60
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Myosin Light Chain 12A (MYL12A) Antibody

abx235484-100ug 100 ug
EUR 577.2

Myosin Light Chain 12B (MYL12B) Antibody

abx235485-100ug 100 ug
EUR 610.8

Myosin Light Chain 12B (MYL12B) Antibody

20-abx241894
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Myosin Light Chain 12B (MYL12B) Antibody

20-abx242152
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Myosin Light Chain 12A (MYL12A) Antibody

20-abx102464
  • EUR 543.60
  • EUR 159.60
  • EUR 1562.40
  • EUR 744.00
  • EUR 410.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myosin Light Chain 12B (MYL12B) Antibody

20-abx102465
  • EUR 510.00
  • EUR 159.60
  • EUR 1446.00
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myosin Light Chain 12B (MYL12B) Antibody

20-abx113949
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Myosin Light Chain 12B (MYL12B) Antibody

abx031145-400ul 400 ul
EUR 627.6

Myosin Light Chain 12B (MYL12B) Antibody

abx031145-80l 80 µl
EUR 343.2

Myosin Light Chain 12A (MYL12A) Antibody

20-abx123512
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Myosin Light Chain 12B (MYL12B) Antibody

20-abx003905
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Myosin Light Chain 2 Antibody / MLC2 / MYL2

F54326-0.05ML 0.05 ml
EUR 140.25
Description: Contractile protein that plays a role in heart development and function (By similarity). Following phosphorylation, plays a role in cross-bridge cycling kinetics and cardiac muscle contraction by increasing myosin lever arm stiffness and promoting myosin head diffusion; as a consequence of the increase in maximum contraction force and calcium sensitivity of contraction force. These events altogether slow down myosin kinetics and prolong duty cycle resulting in accumulated myosins being cooperatively recruited to actin binding sites to sustain thin filament activation as a means to fine-tune myofilament calcium sensitivity to force (By similarity). During cardiogenesis plays an early role in cardiac contractility by promoting cardiac myofibril assembly (By similarity). [UniProt]

Myosin Light Chain 2 Antibody / MLC2 / MYL2

F54326-0.2ML 0.2 ml
EUR 322.15
Description: Contractile protein that plays a role in heart development and function (By similarity). Following phosphorylation, plays a role in cross-bridge cycling kinetics and cardiac muscle contraction by increasing myosin lever arm stiffness and promoting myosin head diffusion; as a consequence of the increase in maximum contraction force and calcium sensitivity of contraction force. These events altogether slow down myosin kinetics and prolong duty cycle resulting in accumulated myosins being cooperatively recruited to actin binding sites to sustain thin filament activation as a means to fine-tune myofilament calcium sensitivity to force (By similarity). During cardiogenesis plays an early role in cardiac contractility by promoting cardiac myofibril assembly (By similarity). [UniProt]

Myosin Light Chain 2 Antibody / MLC2 / MYL2

RQ5348 100ul
EUR 356.15
Description: The MYL2 gene encodes the regulatory light chain associated with cardiac myosin beta (or slow) heavy chain. Ca+ triggers the phosphorylation of regulatory light chain that in turn triggers contraction. Mutations in this gene are associated with mid-left ventricular chamber type hypertrophic cardiomyopathy.

Myosin Light Chain Kinase (MYLK) Antibody

20-abx102570
  • EUR 493.20
  • EUR 159.60
  • EUR 1378.80
  • EUR 678.00
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myosin Light Chain Kinase (MYLK) Antibody

20-abx102571
  • EUR 510.00
  • EUR 159.60
  • EUR 1412.40
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myosin Light Chain Kinase (MYLK) Antibody

20-abx173690
  • EUR 978.00
  • EUR 510.00
  • 1 mg
  • 200 ug

Myosin Light Chain Kinase (MYLK) Antibody

20-abx173691
  • EUR 1045.20
  • EUR 543.60
  • 1 mg
  • 200 ug

Myosin Light Chain Kinase (MYLK) Antibody

20-abx177689
  • EUR 1496.40
  • EUR 710.40
  • 1 mg
  • 200 ug

Myosin Light Chain Kinase (MYLK) Antibody

20-abx113935
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Myosin Light Chain Kinase (MYLK) Antibody

abx433005-200ul 200 ul
EUR 460.8

MYLK Antibody / Myosin light chain kinase

RQ4328 100 ug
EUR 356.15
Description: Myosin light chain kinase, smooth muscle also known as kinase-related protein (KRP) or telokin is an enzyme that in humans is encoded by the MYLK gene. This gene, a muscle member of the immunoglobulin gene superfamily, encodes myosin light chain kinase which is a calcium/calmodulin dependent enzyme. This kinase phosphorylates myosin regulatory light chains to facilitate myosin interaction with actin filaments to produce contractile activity. This gene encodes both smooth muscle and nonmuscle isoforms. In addition, using a separate promoter in an intron in the 3' region, it encodes telokin, a small protein identical in sequence to the C-terminus of myosin light chain kinase, that is independently expressed in smooth muscle and functions to stabilize unphosphorylated myosin filaments. A pseudogene is located on the p arm of chromosome 3. Four transcript variants that produce four isoforms of the calcium/calmodulin dependent enzyme have been identified as well as two transcripts that produce two isoforms of telokin.

Myosin Light Chain 2 Conjugated Antibody

C49023 100ul
EUR 476.4

Myosin Light Chain 2 (Ab-19) Antibody

21157-100ul 100ul
EUR 302.4

Myosin Light Chain 2 (Ab-19) Antibody

21157-50ul 50ul
EUR 224.4

Myosin Light Chain 2 (Ab-18) Antibody

E021157-1 50μg/50μl
EUR 100
Description: Available in various conjugation types.

Myosin Light Chain 2 (Ab-18) Antibody

E021157-2 100μg/100μl
EUR 170
Description: Available in various conjugation types.

Myosin light chain kinase Conjugated Antibody

C48846 100ul
EUR 476.4

Myosin Light Chain Kinase 4 (MYLK4) Antibody

20-abx135920
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Myosin Light Chain 12B (MYL12B) Antibody (FITC)

20-abx271224
  • EUR 577.20
  • EUR 292.80
  • EUR 1696.80
  • EUR 794.40
  • EUR 427.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myosin Light Chain Kinase 2 (MYLK2) Antibody

abx235494-100ug 100 ug
EUR 661.2

Myosin Light Chain Kinase 3 (MYLK3) Antibody

abx235495-100ug 100 ug
EUR 661.2

Myosin Light Chain Kinase 4 (MYLK4) Antibody

abx235496-100ug 100 ug
EUR 661.2

Myosin Light Chain Kinase 3 (MYLK3) Antibody

20-abx241249
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Myosin Light Chain Kinase 3 (MYLK3) Antibody

20-abx102917
  • EUR 526.80
  • EUR 159.60
  • EUR 1479.60
  • EUR 710.40
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myosin Light Chain Kinase 4 (MYLK4) Antibody

20-abx102919
  • EUR 526.80
  • EUR 159.60
  • EUR 1479.60
  • EUR 710.40
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myosin Light Chain Kinase 3 (MYLK3) Antibody

20-abx104995
  • EUR 510.00
  • EUR 159.60
  • EUR 1446.00
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myosin Light Chain Kinase 2 (MYLK2) Antibody

20-abx214285
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Myosin Light Chain Kinase 4 (MYLK4) Antibody

20-abx321153
  • EUR 526.80
  • EUR 393.60
  • 100 ul
  • 50 ul

Myosin Light Chain Kinase 4 (MYLK4) Antibody

20-abx321154
  • EUR 526.80
  • EUR 393.60
  • 100 ul
  • 50 ul

Myosin Light Chain Kinase 2 (MYLK2) Antibody

20-abx113936
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Myosin Light Chain Kinase 3 (MYLK3) Antibody

20-abx113937
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Myosin Light Chain Kinase 4 (MYLK4) Antibody

abx032677-400ul 400 ul
EUR 627.6

Myosin Light Chain Kinase 4 (MYLK4) Antibody

abx032677-80l 80 µl
EUR 343.2

Myosin Light Chain Kinase 2 (MYLK2) Antibody

abx037057-100ug 100 ug
EUR 469.2

Myosin Light Chain Kinase 4 (MYLK4) Antibody

abx037348-100ug 100 ug
EUR 469.2

Myosin Light Chain Kinase 2 (MYLK2) Antibody

20-abx128166
  • EUR 510.00
  • EUR 159.60
  • EUR 1446.00
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myosin Light Chain Kinase 2 (MYLK2) Antibody

20-abx129421
  • EUR 376.80
  • EUR 159.60
  • EUR 994.80
  • EUR 526.80
  • EUR 326.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myosin Light Chain Kinase 2 (MYLK2) Antibody

20-abx131236
  • EUR 543.60
  • EUR 159.60
  • EUR 1562.40
  • EUR 744.00
  • EUR 410.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myosin Light Chain Kinase 3 (MYLK3) Antibody

20-abx320704
  • EUR 526.80
  • EUR 393.60
  • 100 ul
  • 50 ul

Myosin Light Chain Kinase 3 (MYLK3) Antibody

20-abx005109
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Myosin Light Chain 12B (MYL12B) Antibody (Biotin)

20-abx271490
  • EUR 543.60
  • EUR 292.80
  • EUR 1579.20
  • EUR 744.00
  • EUR 410.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myosin Light Chain 9, Regulatory (MYL9) Antibody

20-abx241057
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Myosin Light Chain 9, Regulatory (MYL9) Antibody

20-abx241058
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Myosin Light Chain 7, Regulatory (MYL7) Antibody

abx235490-100ug 100 ug
EUR 577.2

Myosin Light Chain 9, Regulatory (MYL9) Antibody

abx235491-100ug 100 ug
EUR 577.2

Myosin Light Chain 7, Regulatory (MYL7) Antibody

20-abx103354
  • EUR 510.00
  • EUR 159.60
  • EUR 1446.00
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myosin Light Chain 9, Regulatory (MYL9) Antibody

20-abx103355
  • EUR 510.00
  • EUR 159.60
  • EUR 1446.00
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myosin Light Chain 9, Regulatory (MYL9) Antibody

20-abx173689
  • EUR 1028.40
  • EUR 526.80
  • 1 mg
  • 200 ug

Myosin Light Chain 9, Regulatory (MYL9) Antibody

20-abx133618
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Myosin Light Chain 7, Regulatory (MYL7) Antibody

20-abx322622
  • EUR 526.80
  • EUR 393.60
  • 100 ul
  • 50 ul

Myosin Light Chain 9, Regulatory (MYL9) Antibody

abx331954-100ul 100 ul
EUR 510

Myosin Light Chain 2 (Phospho-Ser19) Antibody

11114-100ul 100ul
EUR 302.4

Myosin Light Chain 2 (Phospho-Ser19) Antibody

11114-50ul 50ul
EUR 224.4

Myosin Light Chain 7, Regulatory (MYL7) Antibody

20-abx113954
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Myosin Light Chain 9, Regulatory (MYL9) Antibody

20-abx113955
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Myosin Light Chain 9, Regulatory (MYL9) Antibody

abx028221-400ul 400 ul
EUR 627.6

Myosin Light Chain 9, Regulatory (MYL9) Antibody

abx028221-80l 80 µl
EUR 343.2

Myosin Light Chain 7, Regulatory (MYL7) Antibody

abx122842-100ug 100 ug
EUR 469.2

Myosin Light Chain 7, Regulatory (MYL7) Antibody

20-abx329879
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Myosin Light Chain 9, Regulatory (MYL9) Antibody

20-abx002197
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Myosin Light Chain 7, Regulatory (MYL7) Antibody

20-abx008078
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Myosin Light Chain 7, Regulatory (MYL7) Antibody

20-abx003728
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Myosin Light Chain 7, Regulatory (MYL7) Antibody

20-abx015111
  • EUR 376.80
  • EUR 117.60
  • EUR 477.60
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Myosin Light Chain 9, Regulatory (MYL9) Antibody

20-abx302223
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Myosin Light Chain 2 (Phospho-Ser18) Antibody

E011114-1 50μg/50μl
EUR 145
Description: Available in various conjugation types.

Myosin Light Chain 2 (Phospho-Ser18) Antibody

E011114-2 100μg/100μl
EUR 225
Description: Available in various conjugation types.

Myosin Light Chain 1 (MYL1) Polyclonal Antibody

CAU26499-100ul 100ul
EUR 241.9

Myosin Light Chain 1 (MYL1) Polyclonal Antibody

CAU26499-200ul 200ul
EUR 302.4

Myosin Light Chain 1 (MYL1) Polyclonal Antibody

CAU26500-100ul 100ul
EUR 222.7

Myosin Light Chain 1 (MYL1) Polyclonal Antibody

CAU26500-200ul 200ul
EUR 278.9

Myosin Light Chain 2 (MYL2) Polyclonal Antibody

CAU26502-100ul 100ul
EUR 222.7

Myosin Light Chain 2 (MYL2) Polyclonal Antibody

CAU26502-200ul 200ul
EUR 278.9

Myosin Light Chain 2

E8ET1611-13 100ul
EUR 275
Description: Available in various conjugation types.

Myosin Light Chain 2

E8R1512-19 100ul
EUR 275
Description: Available in various conjugation types.

Myosin Light Chain 12B (MYL12B) Polyclonal Antibody

CAU23325-100ul 100ul
EUR 235.2

Myosin Light Chain 12B (MYL12B) Polyclonal Antibody

CAU23325-200ul 200ul
EUR 294

Myosin Light Chain 12A (MYL12A) Polyclonal Antibody

CAU21125-100ul 100ul
EUR 258.2

Myosin Light Chain 12A (MYL12A) Polyclonal Antibody

CAU21125-200ul 200ul
EUR 322.6

Myosin Light Chain Kinase (MYLK) Polyclonal Antibody

CAU26497-100ul 100ul
EUR 229.4

Myosin Light Chain Kinase (MYLK) Polyclonal Antibody

CAU26497-200ul 200ul
EUR 287.3

Myosin Light Chain Kinase (MYLK) Polyclonal Antibody

CAU26498-100ul 100ul
EUR 222.7

Myosin Light Chain Kinase (MYLK) Polyclonal Antibody

CAU26498-200ul 200ul
EUR 278.9

Myosin light chain kinase

E8ET1608-68 100ul
EUR 275
Description: Available in various conjugation types.

Myosin Light Chain 2 recombinant monoclonal antibody

A5655 100ul X 3
EUR 714
Description: A recombinant monoclonal antibody from rabbit against human Myosin Light Chain 2 for WB, IHC,ELISA

Myosin Light Chain 2 (Ab-19) Conjugated Antibody

C21157 100ul
EUR 476.4

Myosin Light Chain protein

30-1188 100 ug
EUR 787.2
Description: Purified native Human Myosin Light Chain protein

Myosin Light Chain 9, Regulatory (MYL9) Antibody (HRP)

20-abx315314
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Myosin Light Chain Kinase 4 (MYLK4) Antibody (Biotin)

20-abx274594
  • EUR 560.40
  • EUR 292.80
  • EUR 1612.80
  • EUR 760.80
  • EUR 410.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myosin regulatory light chain 2 (pS18) Antibody

abx216882-100ug 100 ug
EUR 526.8
Conclusions: The findings will probably be an obtainable reference to guage the efficacy and security of complementary and different therapies on GERD and will present decision-making reference on which technique to decide on for clinicians.



Leave a Reply

Your email address will not be published.